• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用一系列对症状机制敏感的任务来识别临床上有精神病高风险的个体。

Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms.

作者信息

Williams Trevor, Gold Jim, Waltz James, Schiffman Jason, Ellman Lauren, Strauss Gregory P, Walker Elaine, Woods Scott W, Powers Al, Kenney Joshua, Pappu Minerva, Corlett Philip, Tran Tanya, Silverstein Steven, Zinbarg Richard, Mittal Vijay

机构信息

Kent State University.

MPRC.

出版信息

Res Sq. 2025 May 8:rs.3.rs-5005564. doi: 10.21203/rs.3.rs-5005564/v1.

DOI:10.21203/rs.3.rs-5005564/v1
PMID:40386423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12083675/
Abstract

The clinical high risk for psychosis (CHR-P) population is important for understanding disease progression and treatment; however, standard approaches to identifying CHR-P individuals are expensive and labor-intensive. Focusing on neurocognitive mechanisms that underlie individual psychosis symptoms (positive, negative, and disorganization) may improve screening and identification. The present study examines whether a behavioral task battery that assays symptom mechanisms can identify CHR-P individuals and predict risk severity. Participants ( = 621) were recruited from clinics and the community as part of the Computerized Assessment of Psychosis Risk (CAPR) consortium study. Structured clinical interviews, a dimensional risk calculator, and behavioral tasks were administered. Clinical interviews identified the following groups: (a) CHR-P ( = 273), (b) non-CHR-P individuals with limited psychosis like experiences (PLEs; = 120), (c) participants with mental disorders and no PLEs (CLN; = 82), and (d) healthy controls (HC; = 146). Multinomial logistic regression indicated that the task battery differentiated groups ( < .001), with utility for identifying CHR-P individuals (Sensitivity = .87, PPV = .51, NPV = .77), though with high false positives that varied based on comparison group (Specificity = .21-.43). Tasks also predicted psychosis risk calculator scores (Adjusted = .12), with the two unique predictors being positive symptom task variables associated with updating beliefs regarding environmental volatility. Overall, symptom mechanism tasks differentiated CHR-P individuals from control groups, suggesting their potential as novel screening tools. Using tasks to more efficiently identify CHR-P individuals (e.g., enrich samples), may lower barriers and identify individuals that may otherwise be missed.

摘要

临床精神病高危人群(CHR-P)对于理解疾病进展和治疗至关重要;然而,识别CHR-P个体的标准方法既昂贵又耗费人力。关注构成个体精神病症状(阳性、阴性和紊乱)基础的神经认知机制可能会改善筛查和识别。本研究考察了一组检测症状机制的行为任务能否识别CHR-P个体并预测风险严重程度。作为精神病风险计算机化评估(CAPR)联盟研究的一部分,从诊所和社区招募了参与者(n = 621)。进行了结构化临床访谈、维度风险计算器和行为任务。临床访谈确定了以下几组:(a)CHR-P(n = 273),(b)有有限精神病样体验(PLEs)的非CHR-P个体(n = 120),(c)患有精神障碍且无PLEs的参与者(CLN;n = 82),以及(d)健康对照(HC;n = 146)。多项逻辑回归表明,该任务组能够区分不同组(p <.001),对识别CHR-P个体有用(敏感性 =.87,阳性预测值 =.51,阴性预测值 =.77),尽管假阳性率较高,且因比较组而异(特异性 =.21 -.43)。任务还预测了精神病风险计算器得分(调整后R² =.12),两个独特的预测因素是与更新关于环境波动性信念相关的阳性症状任务变量。总体而言,症状机制任务能够区分CHR-P个体与对照组,表明它们作为新型筛查工具的潜力。使用任务更有效地识别CHR-P个体(例如,丰富样本),可能会降低障碍并识别那些否则可能被遗漏的个体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/295c/12083675/cb0324ac3aaa/nihpp-rs5005564v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/295c/12083675/cb0324ac3aaa/nihpp-rs5005564v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/295c/12083675/cb0324ac3aaa/nihpp-rs5005564v1-f0001.jpg

相似文献

1
Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms.使用一系列对症状机制敏感的任务来识别临床上有精神病高风险的个体。
Res Sq. 2025 May 8:rs.3.rs-5005564. doi: 10.21203/rs.3.rs-5005564/v1.
2
Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms.使用一系列对症状机制敏感的任务来识别临床上有精神病高风险的个体。
Transl Psychiatry. 2025 Aug 23;15(1):311. doi: 10.1038/s41398-025-03539-5.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
The moderating role of lifetime social engagement on the relationship between C-reactive protein and negative symptoms among young adults at clinical high risk for psychosis.终生社交参与对临床高危青年成人中C反应蛋白与阴性症状之间关系的调节作用。
Brain Behav Immun. 2025 Jul 27;129:890-897. doi: 10.1016/j.bbi.2025.07.023.
5
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
6
Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis.临床精神病高危人群脑形态计量学的规范建模。
JAMA Psychiatry. 2024 Jan 1;81(1):77-88. doi: 10.1001/jamapsychiatry.2023.3850.
7
Cognitive subtypes in youth at clinical high risk for psychosis.临床高危青年精神病患者的认知亚型
medRxiv. 2024 Aug 8:2024.08.07.24311240. doi: 10.1101/2024.08.07.24311240.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
10
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.

本文引用的文献

1
Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.PSYCHS 的制定:与 SIPS 协调一致的 CAARMS 的积极症状和诊断标准。
Early Interv Psychiatry. 2024 Apr;18(4):255-272. doi: 10.1111/eip.13457. Epub 2023 Aug 28.
2
Paranoia and belief updating during the COVID-19 crisis.新冠疫情期间的偏执与信念更新。
Nat Hum Behav. 2021 Sep;5(9):1190-1202. doi: 10.1038/s41562-021-01176-8. Epub 2021 Jul 27.
3
Computerized Assessment of Psychosis Risk.精神病风险的计算机化评估
J Psychiatr Brain Sci. 2021;6(3). doi: 10.20900/jpbs.20210011. Epub 2021 Jun 29.
4
Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis.临床高风险个体向精神病转化的概率:一项更新的荟萃分析。
JAMA Psychiatry. 2021 Sep 1;78(9):970-978. doi: 10.1001/jamapsychiatry.2021.0830.
5
Increased face detection responses on the mooney faces test in people at clinical high risk for psychosis.在临床高风险精神病患者中,对穆尼面孔测试的面部检测反应增强。
NPJ Schizophr. 2021 May 17;7(1):26. doi: 10.1038/s41537-021-00156-1.
6
The Critical Need for Help-Seeking Controls in Clinical High-Risk Research.临床高风险研究中对寻求帮助控制措施的迫切需求。
Clin Psychol Sci. 2019 Nov;7(6):1171-1189. doi: 10.1177/2167702619855660. Epub 2019 Sep 23.
7
Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia.腺苷调节剂和钙通道阻滞剂作为精神分裂症的附加治疗方法。
NPJ Schizophr. 2021 Jan 21;7(1):1. doi: 10.1038/s41537-020-00135-y.
8
Enhancing Psychosis Risk Prediction Through Computational Cognitive Neuroscience.通过计算认知神经科学提高精神病风险预测能力。
Schizophr Bull. 2020 Dec 1;46(6):1346-1352. doi: 10.1093/schbul/sbaa091.
9
North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description.北美前驱症状纵向研究(NAPLS 3):方法与基线描述。
Schizophr Res. 2022 May;243:262-267. doi: 10.1016/j.schres.2020.04.010. Epub 2020 Apr 18.
10
Individualized Diagnostic and Prognostic Models for Patients With Psychosis Risk Syndromes: A Meta-analytic View on the State of the Art.个体化诊断和预后模型在精神病风险综合征患者中的应用:对现状的荟萃分析。
Biol Psychiatry. 2020 Aug 15;88(4):349-360. doi: 10.1016/j.biopsych.2020.02.009. Epub 2020 Feb 20.